MDAI

Spectral AI Inc. (MDAI)

Market Closed
5 Dec, 20:00
NASDAQ (CM) NASDAQ (CM)
$
1. 65
-0.04
-2.37%
$
48.79M Market Cap
- P/E Ratio
0% Div Yield
412,050 Volume
0 Eps
$ 1.69
Previous Close
Day Range
1.63 1.75
Year Range
1.04 3.25
Want to track MDAI and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

MDAI closed Friday lower at $1.65, a decrease of 2.37% from Thursday's close, completing a monthly increase of 4.43% or $0.07. Over the past 12 months, MDAI stock lost -42.71%.
MDAI is not paying dividends to its shareholders.
The last earnings report, released on Nov 12, 2025, missed the consensus estimates by -0.05%. On average, the company has surpassed earnings expectations by 0.04%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on NASDAQ (CM) (USD).

MDAI Chart

Similar

Cytosorbents Corporation
$ 0.73
-1.2%
Kalaris Therapeutics, Inc.
$ 9.81
+4.14%
CUE
Cue Biopharma Inc.
$ 0.57
+3.07%
IceCure Medical Ltd.
$ 0.69
+1.1%
Onemednet Corp.
$ 1.77
-3.8%
Spectral AI, Inc. (MDAI) Q2 2025 Earnings Call Transcript

Spectral AI, Inc. (MDAI) Q2 2025 Earnings Call Transcript

Spectral AI, Inc. (NASDAQ:MDAI ) Q2 2025 Earnings Conference Call August 12, 2025 5:00 PM ET Company Participants Dr.Michael DiMaio - Chairman of the Board Sara Prendergast - Corporate Participant Assistant General Counsel - Corporate Participant Vincent Stanley Capone - CFO, General Counsel & Corporate Secretary Conference Call Participants Carl Edward Byrnes - Northland Capital Markets, Research Division John D. Vandermosten - Zacks Small-Cap Research Ryan Benjamin Zimmerman - BTIG, LLC, Research Division Operator Good afternoon, everyone, and welcome to the Spectral AI Inc. Q2 2025 Financial Results Conference Call.

Seekingalpha | 3 months ago
Spectral AI, Inc. (MDAI) Q1 2025 Earnings Call Transcript

Spectral AI, Inc. (MDAI) Q1 2025 Earnings Call Transcript

Spectral AI, Inc. (NASDAQ:MDAI ) Q1 2025 Earnings Conference Call May 13, 2025 5:00 PM ET Company Participants Sara Prendergast - Assistant General Counsel Vincent Capone - CFO Conference Call Participants Ryan Zimmerman - BTIG Carl Byrnes - Northland Capital Markets John Vandermosten - Zacks Vadim Khalil - SP Angel Operator Good day, and welcome to the Spectral AI, Inc. First Quarter 2025 Financial Results Conference Call. [Operator Instructions] Please note that this event is being recorded.

Seekingalpha | 6 months ago
Spectral AI, Inc. (MDAI) Q4 2024 Earnings Call Transcript

Spectral AI, Inc. (MDAI) Q4 2024 Earnings Call Transcript

Spectral AI, Inc. (NASDAQ:MDAI ) Q4 2024 Earnings Conference Call March 27, 2025 5:00 PM ET Company Participants Sara Prendergast - Assistant General Counsel Michael DiMaio - Chairman Vincent Capone - CFO Jihang Wang - Director of Data Science at Spectral AI Conference Call Participants Carl Byrnes - Northland Capital Markets Ryan Zimmerman - BTIG John Vandermosten - Zacks RK Ramakanth - H.C. Wainwright Operator Good afternoon, and welcome to the Spectral AI Fourth Quarter and Full Year 2024 Financial Results Conference Call.

Seekingalpha | 8 months ago

Spectral AI Inc. (MDAI) FAQ

What is the stock price today?

The current price is $1.65.

On which exchange is it traded?

Spectral AI Inc. is listed on NASDAQ (CM).

What is its stock symbol?

The ticker symbol is MDAI.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0%.

What is its market cap?

As of today, the market cap is 48.79M.

Has Spectral AI Inc. ever had a stock split?

No, there has never been a stock split.

Spectral AI Inc. Profile

Health Care Technology Industry
Healthcare Sector
Wensheng Fan CEO
NASDAQ (CM) Exchange
84757T105 CUSIP
US Country
78 Employees
- Last Dividend
- Last Split
6 Apr 2021 IPO Date

Overview

Spectral AI, Inc. is at the forefront of artificial intelligence (AI) innovation, specializing in the field of medical diagnostics. Based in Dallas, Texas, the company's mission focuses on enhancing the speed and accuracy of treatment decisions for patients suffering from burns, diabetic foot ulcers, and similar complex wounds. By integrating AI into the process of medical diagnostics, Spectral AI, Inc. aims to revolutionize the way clinicians assess and approach wound care, ultimately contributing to more effective patient outcomes and the advancement of healthcare technology.

Products and Services

  • DeepView:

A cornerstone product of Spectral AI, Inc., DeepView leverages predictive diagnostics technology to provide clinicians with an objective and immediate assessment of a wound's healing potential. This AI-powered device is designed to help healthcare professionals make informed treatment decisions by evaluating numerous factors that influence wound recovery. The goal of DeepView is to improve the quality of wound care treatments, reduce recovery times, and minimize the risk of complications, thereby enhancing the overall patient care experience in cases of burns and diabetic foot ulcers.

Contact Information

Address: 2515 McKinney Avenue
Phone: 972-499-4934